186 related articles for article (PubMed ID: 22372505)
1. Cytokine network: new targeted therapy for pancreatic cancer.
Matsuo Y; Takeyama H; Guha S
Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
4. Targeting hypoxic tumor microenvironment in pancreatic cancer.
Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
[TBL] [Abstract][Full Text] [Related]
5. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
[TBL] [Abstract][Full Text] [Related]
7. Interventions that induce modifications in the tumor microenvironment.
Bernhard EJ
Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
[TBL] [Abstract][Full Text] [Related]
8. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
Cui J; Jiang W; Wang S; Wang L; Xie K
Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
[TBL] [Abstract][Full Text] [Related]
9. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
Tanaka S
Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.
Marchesi F; Grizzi F; Laghi L; Mantovani A; Allavena P
Curr Pharm Des; 2012; 18(17):2432-8. PubMed ID: 22372498
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.
Mittal K; Ebos J; Rini B
Semin Oncol; 2014 Apr; 41(2):235-51. PubMed ID: 24787295
[TBL] [Abstract][Full Text] [Related]
12. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
Liu G; Chen Y; Qi F; Jia L; Lu XA; He T; Fu Y; Li L; Luo Y
J Pathol; 2015 Oct; 237(2):190-202. PubMed ID: 25988668
[TBL] [Abstract][Full Text] [Related]
13. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in pancreatic cancer: current research status and clinical implications.
Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
[TBL] [Abstract][Full Text] [Related]
15. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
Craven KE; Gore J; Korc M
Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
Rucki AA; Zheng L
World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
[TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cytokines in human pancreatic cancer.
Roshani R; McCarthy F; Hagemann T
Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
